The PE ratio for ELI LILLY stock stands at 107.77 as of May 3, 2024. This is calculated based on the current EPS of $6.82 and the stock price of $734.97 per share. An increase of 15% has been seen in the P/E ratio compared to the average of 94.1 of the last 4 quarters.
Over the last ten years, the average PE ratio of ELI LILLY has been 45.83. The current 107.77 PE ratio is 135% above the historical average. Over the past ten years, LLY's PE ratio was at its highest in the Sep 2018 quarter at 228.32, with a price of $107.31 and an EPS of $0.47. The Sep 2019 quarter recorded the bottom point at 13.57, with a price of $111.83 and an EPS of $8.24.
Maximum annual increase: 162.65% in 2014
Maximum annual decrease: -60.05% in 2019
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 100.16 | 89.73% |
| 2022 | 52.79 | 17.55% |
| 2021 | 44.91 | 81.38% |
| 2020 | 24.76 | 68.21% |
| 2019 | 14.72 | -60.05% |
| 2018 | 36.85 | N/A |
| 2017 | N/A | N/A |
| 2016 | 28.4 | -23.49% |
| 2015 | 37.12 | 19.97% |
| 2014 | 30.94 | 162.65% |
LLY's current P/E ratio is above the 3, 5 and 10-year historical averages.
Compared to its peer MRK, LLY's PE ratio stands lower, however it is higher than JNJ's and ABBV's. ELI LILLY's PE ratio is trading above the peer group average of 36.35.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 9.78 | $359.25B |
| NVS Novartis AG | 13.13 | $198.47B |
| AZN Astrazeneca plc | 37.24 | $236.71B |
| AMGN Amgen Inc | 44.22 | $166.99B |
| ABBV AbbVie Inc | 48.6 | $289.23B |
| PFE Pfizer Inc | 73.18 | $157.04B |
| LLY ELI LILLY & Co | 107.77 | $698.52B |
| MRK Merck & Co Inc | 910.79 | $322.94B |
| BMY Bristol Myers Squibb Co | N/A | $89.17B |
The price to earnings ratio for LLY stock is 107.77 as of May 3, 2024.
As an average over the last 3 years, LLY stock has a PE ratio of 61.68.
As an average over the last 5 years, LLY stock has a PE ratio of 45.42.
The highest quarterly PE ratio in the last ten years has been 228.32 and it was in the Sep 2018 quarter.
The current price to earnings ratio of LLY is 135% higher than the 10-year historical average.
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (May 3, 2024), ELI LILLY's stock price is $734.97. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $6.82. Therefore, ELI LILLY's P/E ratio for today is 107.77. PE RATIO(107.77) = STOCK PRICE($734.97) / TTM EPS($6.82)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.